Αποτελέσματα Αναζήτησης
23 Ιουν 2023 · derivative litigation lead case no. 2:20-cv-01962-gjp notice of pendency and proposed settlement of stockholder derivative actions to: all record holders and beneficial owners of inovio ...
23 Ιουν 2023 · Summary. On March 31, 2023, Inovio, in its capacity as a nominal defendant, entered into the Stipulation to resolve the Derivative Actions and the Demands, which Stipulation was filed in the United States District Court for the Eastern District of Pennsylvania, Philadelphia Division (the “Court”).
19 Ιαν 2023 · Inovio Pharmaceuticals Inc.'s agreement to settle a class action over statements its CEO made about its progress on a Covid-19 vaccine for at least $44 million has garnered final court approval.
26 Αυγ 2022 · Inovio Pharmaceuticals has agreed to settle a shareholder class action lawsuit, which alleged the Plymouth Meeting biotech company made "false and misleading" statements about the development of...
A Pennsylvania federal judge on Wednesday approved a $44 million deal between biotechnology firm Inovio Pharmaceuticals Inc. and its investors to resolve claims that the company's alleged ...
This website has been established to provide general information related to the proposed settlement of the lawsuit referred to as McDermid v. Inovio Pharmaceuticals, Inc., et al., No. 2:20-cv-01402-GJP (the “Action”), and pending before the Honorable Gerald J. Pappert in the United States District Court for the Eastern District of ...
27 Σεπ 2022 · UNITED STATES DISTRICT COURT. EASTERN DISTRICT OF PENNSYLVANIA. IF YOU PURCHASED OR ACQUIRED INOVIO PHARMACEUTICALS, INC. (“INOVIO”) COMMON STOCK FROM FEBRUARY 14, 2020 THROUGH AUGUST 10,...
